Skip to main content

Wegovy, Ozempic Use Could Complicate Your Surgery

Medically reviewed by Carmen Pope, BPharm. Last updated on March 6, 2024.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, March 6, 2024 -- Weight-loss drugs like Wegovy and Ozempic can increase a person’s risk of throwing up during surgery while under anesthesia, a new study reports.

People are typically asked to fast prior to surgery because general anesthesia can cause nausea, and they might inhale and choke on their own vomit.

Unfortunately, part of the way that these drugs, called GLP-1 receptor agonists, help prompt weight loss is by slowing the digestion process, researchers explained. That means it takes longer for food to pass through the stomach.

About 56% of people on a weight-loss drug still had significant amounts of food in their stomach at the time of their surgery, as revealed by ultrasound, researchers reported March 6 in the journal JAMA Surgery.

Comparatively, only 19% of people not taking a GLP-1 receptor agonist had food left over in their stomach following preoperative fasting, results showed.

“More than half of the patients on a GLP-1 receptor agonist had significant gastric contents on gastric ultrasound before an elective procedure, despite adhering to preoperative fasting,” said lead researcher Dr. Sudipta Sen, an associate professor of anesthesiology with the University of Texas Health Science Center at Houston.

These results jibe with guidance issued last year by the American Society of Anesthesiologists that calls for screening for weight-loss drug use before surgery, and informing patients of the risks involved, researchers said.

Doctors should consider pausing the use of those drugs prior to surgery, the guidelines also state.

“Patients must ensure they disclose their use of this medication to their surgeons and anesthesiologists,” Sen added in a university news release. “This information is crucial for us to provide appropriate recommendations, such as adjusting drug administration before elective procedures, recommending extended fasting, or rescheduling an elective procedure if necessary.”

The research team decided to pursue this study based on anecdotal reports of people on weight-loss drugs aspirating their own vomit during surgery. This can increase risk of death by blocking the patient’s breathing or causing pneumonia.

For this study, researchers performed ultrasound scans on more than 120 patients scheduled for elective procedures between June and July 2023.

Overall, the use of GLP-1 receptor agonists was associated with a nearly 31% prevalence of increased residual food in people’s stomachs despite pre-surgery fasting, researchers found.

New treatment guidelines might be needed that extend fasting for people on weight-loss drugs, Sen concluded.

Sources

  • University of Texas Health Science Center at Houston, news release, March 6, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

PCOS Plus Obesity Can Be Hazardous in Pregnancy

WEDNESDAY, Nov. 6, 2024 -- Women who are pregnant but who also have the ovarian cyst disorder polycystic ovary syndrome (PCOS) are at higher odds of giving birth to an underweight...

U.S. Diabetes Rates Rise to Nearly 1 in 6 Adults

WEDNESDAY, Nov. 6, 2024 -- Nearly 16% of American adults -- that's close to 1 in 6 -- now has diabetes, according to the latest data from the U.S. Centers for Disease Control and...

Medicaid Covers GLP-1 Meds for Obesity in Just 13 States

TUESDAY, Nov. 5, 2024 -- Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.